Investopedia on MSN11d
What To Expect in the Markets This WeekCPI inflation, retail sales, Jerome Powell congressional testimony, along with earnings from Coca-Cola, McDonald’s, Cisco, ...
9d
Zacks.com on MSNVRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product SalesVertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $3.98 per share for the fourth quarter of 2024, ...
The company, helmed by BioNTech alums, is developing therapies aimed at dermatological, respiratory and gut-related ...
Markets were flat but positive in an initial trading day for a new week, basically shrugging off whatever warnings signs may have been considered regarding President Trump’s 25% steel tariff headline ...
Maia, as the AI bot is called, is the first of its kind here and takes only a 0.2% commission. Read more at straitstimes.com.
Home buyers do not have to pay to use the new platform developed by Mogul.sg, which hopes to curate recommended listings from major property portals in Singapore.
Advanced Micro Devices Inc (NASDAQ: AMD) tumbled Wednesday after Citi downgraded the stock from Buy to Neutral, citing ...
13d
Zacks.com on MSNCRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...
SINGAPORE, Feb 6 — Home buyers in Singapore may soon rely on artificial intelligence rather than human agents to find their ...
Vertex Pharmaceuticals Incorporated VRTX reported mixed results for its fourth quarter on Monday. The company posted ...
Biotechnology company Vertex Pharmaceuticals (VRTX) reported mixed results for the fourth quarter of 2024. While revenue surpassed analyst ...
Piper Sandler analyst Christopher Raymond maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results